Forecast & Rating27 analysts currently cover Medline, with about 85.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $44.60, about 21.9% upside from the current price of $36.59. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most professionals who study Medline closely still see room for the stock to rise. Data as of Sep 2, 2026; for reference only and not investment advice.
Sep 1, 2026Price forecast
$44.6021.89%
Forecast & RatingBuy
27analysts
- Strong buy59.26%
- Buy25.93%
- Hold14.81%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 4, 2026
Forecast met19.5%
Stock price$36.59
Avg. target$44.6
High target$55
Low target$34
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.